| Q98466317 | A Natural Dietary Flavone Myricetin as an α-Hemolysin Inhibitor for Controlling Staphylococcus aureus Infection |
| Q57789702 | Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity and Staphylococcus aureus Fitness in Infection Models |
| Q34922452 | Anti-alpha-toxin monoclonal antibody and antibiotic combination therapy improves disease outcome and accelerates healing in a Staphylococcus aureus dermonecrosis model. |
| Q36609408 | Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections |
| Q35622488 | Apolipoprotein B48, the Structural Component of Chylomicrons, Is Sufficient to Antagonize Staphylococcus aureus Quorum-Sensing. |
| Q35356667 | Autophagy mediates tolerance to Staphylococcus aureus alpha-toxin. |
| Q41995627 | Bacterial toxins: Offensive, defensive, or something else altogether? |
| Q35988737 | CD36 Is Essential for Regulation of the Host Innate Response to Staphylococcus aureus α-Toxin-Mediated Dermonecrosis. |
| Q50199724 | Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection |
| Q64077099 | Comparison of livestock-associated and community-associated Staphylococcus aureus pathogenicity in a mouse model of skin and soft tissue infection |
| Q92825023 | Contribution of hla Regulation by SaeR to Staphylococcus aureus USA300 Pathogenesis |
| Q36636170 | Exploiting dominant-negative toxins to combat Staphylococcus aureus pathogenesis |
| Q61800856 | GPER activation protects against epithelial barrier disruption by Staphylococcus aureus α-toxin |
| Q27005777 | Host factors that contribute to recurrent staphylococcal skin infection |
| Q36735408 | Importance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection |
| Q64928558 | Inactivation of farR Causes High Rhodomyrtone Resistance and Increased Pathogenicity in Staphylococcus aureus. |
| Q91745147 | Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination |
| Q37611964 | Innate Immune Memory Contributes to Host Defense against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus |
| Q35677564 | Methicillin-resistant Staphylococcus aureus adaptation to human keratinocytes |
| Q47193259 | Neutralizing α-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice. |
| Q28080781 | Pathogenesis of Staphylococcus aureus abscesses |
| Q60952635 | Pharmacological Targeting of Pore-Forming Toxins as Adjunctive Therapy for Invasive Bacterial Infection |
| Q39173330 | Pharmacological Targeting of the Host-Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs |
| Q36005464 | Prevention of Recurrent Staphylococcal Skin Infections |
| Q35947359 | Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection |
| Q62478185 | Sequential evolution of virulence and resistance during clonal spread of community-acquired methicillin-resistant |
| Q33690186 | Simple Wound Irrigation in the Postoperative Treatment for Surgically Drained Spontaneous Soft Tissue Abscesses: Study Protocol for a Prospective, Single-Blinded, Randomized Controlled Trial. |
| Q30239977 | Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach? |
| Q48319147 | Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314. |
| Q64905555 | Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus. |
| Q36274821 | Synergistic Action of Staphylococcus aureus α-Toxin on Platelets and Myeloid Lineage Cells Contributes to Lethal Sepsis |
| Q26752975 | Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy |
| Q29994694 | The S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens |
| Q38805996 | The complex biology and contribution of Staphylococcus aureus in atopic dermatitis, current and future therapies. |
| Q36306086 | The ever-emerging complexity of α-toxin's interaction with host cells |
| Q33677615 | VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation |
| Q90392500 | α-Toxin Induces Platelet Aggregation and Liver Injury during Staphylococcus aureus Sepsis |
| Q40124323 | α-Toxin Regulates Local Granulocyte Expansion from Hematopoietic Stem and Progenitor Cells in Staphylococcus aureus-Infected Wounds |
| Q35169008 | ω-Hydroxyemodin limits staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. |